Melasma. Other disorders of pigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People with melasma on the cheeks and other areas of the face
Exclusion criteria
Exclusion criteria: Any complication that is related to the treatment process or is not tolerated by the patient The patient does not want to continue treatment for any reason Cancers, pregnancy, lactation, DVT, pulmonary embolism, stroke Incidence of drug allergies Occurrence of hypertrophic or colloidal scars at the treatment site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melasma area recovery rate. Timepoint: Before treatment and 1 month after the last session. Method of measurement: Visioface. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: 1 months after the last session. Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Skin and stem Cell Research Center, Tehran University of Medical Sciences